(Q40784849)

English

Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long-term follow-up

scientific article published on July 15, 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long-term follow-up (English)

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

1 reference

based on heuristic

inferred from title

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

author name string

I. N. Olver

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

M. M. Wolf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

D. Cruickshank

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

V. Worotniuk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

J. C. Ding

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

I. A. Cooper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

J. P. Matthews

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3383124

3 January 2023

language of work or name

0 references

publication date

1 July 1988

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

15 July 1988

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3383124

3 January 2023

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

233-239

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819880715%2962%3A2%3C233%3A%3AAID-CNCR2820620203%3E3.0.CO%3B2-L

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819880715%2962%3A2%3C233%3A%3AAID-CNCR2820620203%3E3.0.CO%3B2-L

21 January 2018

BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819880715%2962%3A2%3C233%3A%3AAID-CNCR2820620203%3E3.0.CO%3B2-L

21 January 2018

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Combination Chemotherapy of Hodgkin's Disease in Private Practice

3

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission

4

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.

5

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Twenty years of MOPP therapy for Hodgkin's disease

6

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Reporting results of cancer treatment

11

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Analysis of survival by tumor response.

14

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B

15

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease

16

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

18

1 reference

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19880715)62:2%3C233::AID-CNCR2820620203%3E3.0.CO;2-L

3 January 2023

Identifiers

10.1002/1097-0142(19880715)62:2<233::AID-CNCR2820620203>3.0.CO;2-L

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40784849&oldid=1802129625"